FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael verneris

Research Profile

Anatomy

Procedures

Disorders

Phenomena

Recurrence

Concepts & Ideas

Living Beings

Chemicals & Drugs

Receptors, KIR

Co-author Network

Publications

TOP 3
Angela R Smith; Heather E Stefanski; Barbara A Trotz; Michael J Burke; Qing Cao; Ellen C Christiansen; Margaret L MacMillan; John E Wagner; Michael verneris
Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDS.
Michael J Burke; Qing Cao; Nathan Gossai; Margaret L MacMillan; Angela R Smith; Heather S Stefanski; John E Wagner; Daniel J Weisdorf; Veronika Bachanova; Michael verneris
Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.
Nicole A Karras; Jeffrey S Miller; Wendy Sessions; Heather Stefanski; Bruce R Blazar; Claudio G Brunstein; Sarah Cooley; Todd Defor; John E Wagner; Matthew Weeres; Xiyan Xu; Jo-Anne H Young; Michael verneris
A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael verneris (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Angela R Smith; Heather E Stefanski; Barbara A Trotz; Michael J Burke; Qing Cao; Ellen C Christiansen; Margaret L MacMillan; John E Wagner; Michael verneris
Early hematopoietic stem cell transplant is associated with favorable outcomes in children with MDS.
Pediatric blood & cancer 2013;60(4):705-10.
2013: Michael J Burke; Qing Cao; Nathan Gossai; Margaret L MacMillan; Angela R Smith; Heather S Stefanski; John E Wagner; Daniel J Weisdorf; Veronika Bachanova; Michael verneris
Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1):138-42.
2013: Nicole A Karras; Jeffrey S Miller; Wendy Sessions; Heather Stefanski; Bruce R Blazar; Claudio G Brunstein; Sarah Cooley; Todd Defor; John E Wagner; Matthew Weeres; Xiyan Xu; Jo-Anne H Young; Michael verneris
A randomized trial of one versus two doses of influenza vaccine after allogeneic transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(1):109-16.
2012: Michelle K Gleason; Valarie McCullar; Angela Panoskaltsis-Mortari; Deborah A Todhunter; Daniel A Vallera; Michael verneris; Louis M Weiner; Bin Zhang; Sophia X Zhou; Jeffrey S Miller
Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.
Molecular cancer therapeutics 2012;11(12):2674-84.
2012: Bree Foley; Xianghua Luo; Claudio Anasetti; Sarah Cooley; Julie Curtsinger; Michael verneris; Edmund K Waller; Daniel Weisdorf; Jeffrey S Miller
Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(10):5082-8.
2012: Veronika Bachanova; Claudio G Brunstein; Michael J Burke; Qing Cao; Karamjeet Sandhu; Timothy P Singleton; Michael verneris; John E Wagner; Sophia Yohe; Daniel J Weisdorf
Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(6):963-8.
2012: Theodore Honebrink; Karen Larsen; Jeffery S Miller; Claudio G Brunstein; Michael J Burke; Qing Cao; Vanessa Dayton; John E Wagner; Daniel Weisdorf; Michael verneris
Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(6):930-6.
2012: P Ramirez; Michael verneris; John E Wagner; Daniel J Weisdorf; Todd E DeFor; Philip B McGlave; David H McKenna; Jeffrey S Miller; Bruce R Blazar; Claudio G Brunstein
Factors predicting single-unit predominance after double umbilical cord blood transplantation.
Bone marrow transplantation 2012;47(6):799-803.
2012: Michael J Burke; Bruce Lindgen; Michael verneris
Treatment of relapsed acute lymphoblastic leukemia: approaches used by pediatric oncologists and bone marrow transplant physicians.
Pediatric blood & cancer 2012;58(6):840-5.
2012: Michael verneris; John E Wagner
The epic race to immune reconstitution.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(4):493-4.
2012: Steven A Dezell; Harry Dolstra; Scott Jackson; Jeffrey S Miller; Jan Spanholtz; Yong-Oon Ahn; Sarah Cooley; Hongbo Wang; Matthew Weeres; Michael verneris
Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(4):536-45.
2012: Michelle K Gleason; Mitsuomi Hirashima; Carol J Holman; Todd R Lenvik; Valarie McCullar; Bruce R Blazar; Frank Cichocki; Sarah Cooley; Martin Felices; Toshiro Niki; M Shea O'Brien; Angela Panoskaltsis-Mortari; Michael verneris; Jeffrey S Miller
Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.
Blood 2012;119(13):3064-72.
2012: Bree Foley; Lewis L Lanier; Sandra Lopez-Vergès; Xianghua Luo; Sarah Cooley; Julie Curtsinger; Michelle Pitt; Michael verneris; Daniel Weisdorf; Jeffrey S Miller
Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
Blood 2012;119(11):2665-74.
2012: Erica D Warlick; Daniel J Weisdorf; Celalettin Ustun; Michael verneris; Bruce R Blazar; Linda Burns; Todd DeFor; Jeffrey S Miller
Successful remission rates and survival after lymphodepleting chemotherapy and donor lymphocyte infusion for relapsed hematologic malignancies postallogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(3):480-6.
2011: Romee Rizwan; Daniel J Weisdorf; Bruce R Blazar; Todd Defor; James L M Ferarra; John E Levine; Michael verneris
Peritransplant palifermin use and lymphocyte recovery after T-cell replete, matched related allogeneic hematopoietic cell transplantation.
American journal of hematology 2011;86(10):879-82.
2011: Bree Foley; Xianghua Luo; Sarah Cooley; Julie Curtsinger; Michael verneris; Edmund K Waller; Daniel J Weisdorf; Jeffrey S Miller
NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.
Blood 2011;118(10):2784-92.
2011: Erica D Warlick; Mukta Aurora; Veronika Bachanova; Bruce R Blazar; Claudio G Brunstein; Linda J Burns; Qing Cao; Sarah Cooley; Todd E DeFor; Kathryn E Dusenbery; Dan Kaufman; Margaret L MacMillan; Navneet S Majhail; Brian McClune; Philip McGlave; Jeffrey Miller; Betul Oran; Arne Slungaard; Marcie Tomblyn; Gregory Vercellotti; Michael verneris; John Wagner; Daniel J Weisdorf
Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(7):1025-32.
2011: J C Beck; Q Cao; A R Smith; B Trotz; Michael verneris; Brenda J Weigel; M J Burke
Allogeneic hematopoietic cell transplantation outcomes for children with B-precursor acute lymphoblastic leukemia and early or late BM relapse.
Bone marrow transplantation 2011;46(7):950-5.
2011: Michael J Burke; Rachel Isaksson Vogel; Sanyukta K Janardan; Claudio G Brunstein; Angela R Smith; Jeffrey S Miller; Daniel Weisdorf; John E Wagner; Michael verneris
Early lymphocyte recovery and outcomes after umbilical cord blood transplantation (UCBT) for hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(6):831-40.
2011: Veronika Bachanova; Karamjeet Sandhu; Sophia Yohe; Qing Cao; Michael J Burke; Michael verneris; Daniel Weisdorf
Allogeneic hematopoietic stem cell transplantation overcomes the adverse prognostic impact of CD20 expression in acute lymphoblastic leukemia.
Blood 2011;117(19):5261-3.
2011: Bartosz Grzywacz; Nandini Kataria; Niketa Kataria; Bruce R Blazar; Jeffrey S Miller; Michael verneris
Natural killer-cell differentiation by myeloid progenitors.
Blood 2011;117(13):3548-58.
2011: A R Smith; E Gulbahce; M J Burke; Q Cao; Margaret L MacMillan; Jakub Tolar; Paul J Orchard; Bruce R Blazar; K Scott Baker; John E Wagner; Michael verneris
Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant.
Bone marrow transplantation 2011;46(3):368-71.
2010: Yong-Oon Ahn; Brenda J Weigel; Michael verneris
Killing the killer: natural killer cells to treat Ewing's sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(15):3819-21.
2010: Michael verneris; Michael J Burke
Novel approaches to prevent leukemia relapse following allogeneic hematopoietic cell transplantation.
Current hematologic malignancy reports 2010;5(3):157-62.
2010: Jill C Beck; John E Wagner; Todd E DeFor; Claudio G Brunstein; Mark R Schleiss; Jo-Anne Young; Daniel H Weisdorf; Sarah Cooley; Jeffrey S Miller; Michael verneris
Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(2):215-22.
2010: Navneet S Majhail; Jaya M Mothukuri; Margaret L MacMillan; Michael verneris; Paul J Orchard; John E Wagner; Daniel J Weisdorf
Costs of pediatric allogeneic hematopoietic-cell transplantation.
Pediatric blood & cancer 2010;54(1):138-43.
2009: Michael J Burke; Qing Cao; Barb Trotz; Brenda J Weigel; Ashish Kumar; Angela Smith; Michael verneris
Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
Pediatric blood & cancer 2009;53(7):1289-94.
2009: Eric Anderson; Bartosz Grzywacz; Hongbo Wang; Tao Wang; Michael Haagenson; Stephen Spellman; Bruce R Blazar; Jeffrey S Miller; Michael verneris
Limited role of MHC class I chain-related gene A (MICA) typing in assessing graft-versus-host disease risk after fully human leukocyte antigen-matched unrelated donor transplantation.
Blood 2009;114(21):4753-4; author reply 4754-5.
2009: Michael verneris; Claudio G Brunstein; Juliet N Barker; Margaret L MacMillan; Todd E DeFor; David H McKenna; Michael J Burke; Bruce R Blazar; Jeffrey S Miller; Philip B McGlave; Daniel J Weisdorf; John E Wagner
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.
Blood 2009;114(19):4293-9.
2009: Michael verneris; Jeffrey S Miller
The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells.
British journal of haematology 2009;147(2):185-91.
2009: Angela R Smith; K Scott Baker; Todd E DeFor; Michael verneris; John E Wagner; Margaret L MacMillan
Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1086-93.
2009: Michael B Tomblyn; Mukta Arora; K Scott Baker; Bruce R Blazar; Claudio G Brunstein; Linda J Burns; Todd E DeFor; Kathryn E Dusenbery; Dan S Kaufman; John H Kersey; Margaret L MacMillan; Philip B McGlave; Jeffrey S Miller; Paul J Orchard; Arne Slungaard; Marcie R Tomblyn; Gregory M Vercellotti; Michael verneris; John E Wagner; Daniel J Weisdorf
Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(22):3634-41.
2009: M J Burke; B Trotz; X Luo; Daniel J Weisdorf; K Scott Baker; John E Wagner; Michael verneris
Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.
Bone marrow transplantation 2009;44(3):169-74.
2009: Petter S Woll; Bartosz Grzywacz; Xinghui Tian; Rebecca K Marcus; David A Knorr; Michael verneris; Dan S Kaufman
Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.
Blood 2009;113(24):6094-101.
2009: Claudio G Brunstein; John E Wagner; Daniel J Weisdorf; Sarah Cooley; Harriet Noreen; Juliet N Barker; Todd E DeFor; Michael verneris; Bruce R Blazar; Jeffrey S Miller
Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.
Blood 2009;113(22):5628-34.
2009: Veronika Bachanova; Michael verneris; Todd E DeFor; Claudio G Brunstein; Daniel J Weisdorf
Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.
Blood 2009;113(13):2902-5.
2009: Margaret L MacMillan; Daniel J Weisdorf; Claudio G Brunstein; Qing Cao; Todd E DeFor; Michael verneris; Bruce R Blazar; John E Wagner
Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.
Blood 2009;113(11):2410-5.
2009: Susanta K Hui; Michael verneris; Jerry Froelich; Kathryn E Dusenbery; James S Welsh
Multimodality image guided total marrow irradiation and verification of the dose delivered to the lung, PTV, and thoracic bone in a patient: a case study.
Technology in cancer research & treatment 2009;8(1):23-8.
2009: Stephen B Harvey; Yan Zhang; Joshua Wilson-Grady; Teresa Monkkonen; Gary L Nelsestuen; Raj Kasthuri; Michael verneris; Troy Lund; E Wesley Ely; gordon bernard; Harald Zeisler; Monika Homoncik; Bernd Jilma; Therese Swan; Todd A Kellogg
O-glycoside biomarker of apolipoprotein C3: responsiveness to obesity, bariatric surgery, and therapy with metformin, to chronic or severe liver disease and to mortality in severe sepsis and graft vs host disease.
Journal of proteome research 2009;8(2):603-12.
2009: M J Burke; B Trotz; X Luo; K Scott Baker; Daniel J Weisdorf; John E Wagner; Michael verneris
Allo-hematopoietic cell transplantation for Ph chromosome-positive ALL: impact of imatinib on relapse and survival.
Bone marrow transplantation 2009;43(2):107-13.
2008: Qin Tang; Bartosz Grzywacz; Hongbo Wang; Nandini Kataria; Qing Cao; John E Wagner; Bruce R Blazar; Jeffrey S Miller; Michael verneris
Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(7):4507-15.
2008: Bartosz Grzywacz; Jeffrey S Miller; Michael verneris
Use of natural killer cells as immunotherapy for leukaemia.
Best practice & research. Clinical haematology 2008;21(3):467-83.
2008: Paul D Harker-Murray; Avis J Thomas; John E Wagner; Daniel Weisdorf; Xianghua Luo; Todd E DeFor; Michael verneris; Kathryn E Dusenbery; Margaret L MacMillan; Jakub Tolar; K Scott Baker; Paul J Orchard
Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):685-92.
2008: Stephan A Grupp; Michael verneris; Paul M Sondel; Laurence J N Cooper
Immunotherapy for pediatric cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1 Suppl 1):33-43.
2007: P A Jacobson; N Rydhom; J Huang; K Scott Baker; Michael verneris
High-unbound mycophenolic acid concentrations in an infant on peritoneal dialysis following hematopoietic cell transplant.
Bone marrow transplantation 2007;40(9):911-2.
2007: Jeffrey S Miller; Daniel J Weisdorf; Linda J Burns; Arne Slungaard; John E Wagner; Michael verneris; Sarah Cooley; Rosanna Wangen; Susan K Fautsch; Roby Nicklow; Todd E DeFor; Bruce R Blazar
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.
Blood 2007;110(7):2761-3.
2007: Hongbo Wang; Bartosz Grzywacz; David J Sukovich; Valarie McCullar; Qing Cao; Alisa B Lee; Bruce R Blazar; David N Cornfield; Jeffrey S Miller; Michael verneris
The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.
Blood 2007;110(5):1530-9.
2007: Michael verneris; John E Wagner
Recent developments in cell-based immune therapy for neuroblastoma.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2007;2(2):134-9.
2007: Jeffery S Miller; Sarah Cooley; Peter Parham; Sherif S Farag; Michael verneris; Karina L McQueen; Lisbeth A Guethlein; Elizabeth Trachtenberg; Michael Haagenson; Mary M Horowitz; John P Klein; Daniel J Weisdorf
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.
Blood 2007;109(11):5058-61.
2007: Troy Lund; Lorraine B Anderson; Valarie McCullar; LeeAnn Higgins; Gong H Yun; Bartosz Grzywacz; Michael verneris; Jeffrey S Miller
iTRAQ is a useful method to screen for membrane-bound proteins differentially expressed in human natural killer cell types.
Journal of proteome research 2007;6(2):644-53.
2007: Bartosz Grzywacz; N Kataria; Michael verneris
CD56(dim)CD16(+) NK cells downregulate CD16 following target cell induced activation of matrix metalloproteinases.
Leukemia 2007;21(2):356-9; author reply 359.
2007: Susanta K Hui; Michael verneris; P Higgins; Bruce J Gerbi; Brenda J Weigel; S K Baker; C Fraser; M Tomblyn; Kathryn E Dusenbery
Helical tomotherapy targeting total bone marrow - first clinical experience at the University of Minnesota.
Acta oncologica (Stockholm, Sweden) 2007;46(2):250-5.
2006: Bartosz Grzywacz; Nandini Kataria; Magdalena Sikora; Robert Oostendorp; Elaine Dzierzak; Bruce R Blazar; Jeffrey S Miller; Michael verneris
Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.
Blood 2006;108(12):3824-33.
2006: A M Peters; Cindy K Blair; Michael verneris; Joseph P Neglia; Leslie L Robison; Logan G Spector; Gregory H Reaman; C A Felix; Julie A Ross
Maternal hemoglobin concentration during pregnancy and risk of infant leukaemia: a children's oncology group study.
British journal of cancer 2006;95(9):1274-6.
2006: Raj Kasthuri; Michael verneris; Hassan N Ibrahim; Bernd Jilma; Gary L Nelsestuen
Studying multiple protein profiles over time to assess biomarker validity.
Expert review of proteomics 2006;3(4):455-64.
2006: Martin Kornacker; Michael verneris; B Kornacker; Tm Ganten; christian scheffold; Robert S Negrin
The apoptotic and proliferative fate of cytokine-induced killer cells after redirection to tumor cells with bispecific Ab.
Cytotherapy 2006;8(1):13-23.
2006: Christopher J Fraser; Brenda J Weigel; John P Perentesis; Kathryn E Dusenbery; Todd E DeFor; K Scott Baker; Michael verneris
Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors.
Bone marrow transplantation 2006;37(2):175-81.
2005: Mobin Karimi; Thai M Cao; Jeanette A Baker; Michael verneris; Luis Soares; Robert S Negrin
Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(12):7819-28.
2005: Gary L Nelsestuen; Yan Zhang; Michael B Martinez; Nigel S Key; Bernd Jilma; Michael verneris; Alan R Sinaiko; Raj Kasthuri
Plasma protein profiling: unique and stable features of individuals.
Proteomics 2005;5(15):4012-24.
2005: Poh-Lin Tan; Michael verneris; Lawrence Charnas; Samuel J Reck; Jo-Anne H van Burik; Bruce R Blazar
Outcome of CNS and pulmonary enteroviral infections after hematopoietic cell transplantation.
Pediatric blood & cancer 2005;45(1):74-5.
2005: Michael verneris; Arash Arshi; Matthias Edinger; Martin Kornacker; Yasodha Natkunam; Mobin Karami; Yu-An Cao; Neyssa M Marina; Christopher H Contag; Robert S Negrin
Low levels of Her2/neu expressed by Ewing's family tumor cell lines can redirect cytokine-induced killer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(12):4561-70.
2005: Antoinette Peters; J Carlos Manivel; Michelle Dolan; H Evin Gulbahce; K Scott Baker; Michael verneris
Pulmonary cytolytic thrombi after allogeneic hematopoietic cell transplantation: a further histologic description.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(6):484-5.
2004: Michael verneris; Mobin Karami; Jeanette Baker; Anishka Jayaswal; Robert S Negrin
Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells.
Blood 2004;103(8):3065-72.
2003: Matthias Edinger; Yu-An Cao; Michael verneris; Michael H Bachmann; Christopher H Contag; Robert S Negrin
Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging.
Blood 2003;101(2):640-8.
2003: Stanley L Schrier; Filippo Centis; Michael verneris; Lisa Ma; Emanuele Angelucci
The role of oxidant injury in the pathophysiology of human thalassemias.
Redox report : communications in free radical research 2003;8(5):241-5.
2002: Matthias Edinger; Yu-An Cao; Yvette S Hornig; Darlene E Jenkins; Michael verneris; Michael H Bachmann; Robert S Negrin; Christopher H Contag
Advancing animal models of neoplasia through in vivo bioluminescence imaging.
European journal of cancer (Oxford, England : 1990) 2002;38(16):2128-36.
2002: Michael verneris; Jeanette Baker; Matthias Edinger; Robert S Negrin
Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice.
Journal of clinical immunology 2002;22(3):131-6.
2002: Robert S Negrin; Matthias Edinger; Michael verneris; Yu-An Cao; M Bachmann; Christopher Contag
Visualization of tumor growth and response to NK-T cell based immunotherapy using bioluminescence.
Annals of hematology 2002;81 Suppl 2():S44-5.
2001: Martin Kornacker; U Schlattner; Theo Wallimann; Michael verneris; Robert S Negrin; B Kornacker; Andrea Staratschek-Jox; Volker Diehl; Jürgen Wolf
Hodgkin disease-derived cell lines expressing ubiquitous mitochondrial creatine kinase show growth inhibition by cyclocreatine treatment independent of apoptosis.
International journal of cancer. Journal international du cancer 2001;94(4):513-9.
2001: Michael verneris; I R McDougall; D Becton; Michael P Link
Thyroid carcinoma after successful treatment of osteosarcoma: a report of three patients.
Journal of pediatric hematology/oncology 2001;23(5):312-5.
2001: J Baker; Michael verneris; M Ito; Judith A Shizuru; Robert S Negrin
Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.
Blood 2001;97(10):2923-31.
2001: Martin Kornacker; Michael verneris; B Kornacker; christian scheffold; Robert S Negrin
Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells.
Immunology letters 2001;76(3):169-73.
2001: Michael verneris; M Ito; Jeanette Baker; A Arshi; Robert S Negrin; Judith A Shizuru
Engineering hematopoietic grafts: purified allogeneic hematopoietic stem cells plus expanded CD8+ NK-T cells in the treatment of lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(10):532-42.
2001: J Frankovich; S S Donaldson; Y Lee; Ruby M Wong; Michael D Amylon; Michael verneris
High-dose therapy and autologous hematopoietic cell transplantation in children with primary refractory and relapsed Hodgkin's disease: atopy predicts idiopathic diffuse lung injury syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):49-57.
2000: Michael verneris; Martin Kornacker; V Mailänder; Robert S Negrin
Resistance of ex vivo expanded CD3+CD56+ T cells to Fas-mediated apoptosis.
Cancer immunology, immunotherapy : CII 2000;49(6):335-45.
1995: Michael verneris; L Tuel; N L Seibel
Pediatric HIV infection and chronic myelogenous leukemia.
Pediatric AIDS and HIV infection 1995;6(5):292-4.